Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets
23 août 2022 10h54 HE
|
Antisense Therapeutics Limited
World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins in Long COVID-19 patients has elucidated novel blood markers as potential diagnostic and therapeutic...
Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets
22 août 2022 07h40 HE
|
Antisense Therapeutics Limited
World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins in Long COVID-19 patients has elucidated novel blood markers as potential diagnostic and therapeutic...